Federica Lumetti Selected Research

Federica Lumetti Research Topics

9	Systemic Scleroderma (Systemic Sclerosis) 02/2024 - 11/2015
5	digital ulcers 01/2023 - 09/2017
3	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2024 - 11/2017
3	COVID-19 12/2023 - 01/2021
3	Psoriatic Arthritis 02/2023 - 01/2022
3	Ulcer 08/2019 - 02/2012
2	Cicatrix (Scar) 02/2024 - 01/2023
2	Rheumatoid Arthritis 08/2023 - 01/2022
2	Fibrosis (Cirrhosis) 06/2023 - 11/2015
2	Neoplasms (Cancer) 06/2023 - 12/2022
2	Arthritis (Polyarthritis) 10/2022 - 02/2022
2	Sjogren's Syndrome (Sjogren Syndrome) 10/2022 - 01/2022
2	Skin Ulcer 06/2022 - 04/2020
2	Wounds and Injuries (Trauma) 04/2020 - 04/2015
2	Infections 02/2018 - 04/2015
1	Retinoblastoma (Glioblastoma, Retinal) 06/2023
1	Rheumatic Diseases (Rheumatism) 02/2022
1	Spondylarthritis (Spinal Arthritis) 02/2022
1	Ankylosing Spondylitis 01/2022
1	Raynaud Disease (Raynaud's Disease) 01/2022
1	Erythema 04/2020
1	Calcinosis 04/2020
1	Vascular Diseases (Vascular Disease) 08/2019
1	Unstable Angina 06/2019
1	Ischemia 06/2019
1	Myocardial Infarction 06/2019
1	Osteomyelitis 02/2018
1	Gangrene 02/2018
1	Body Weight (Weight, Body) 09/2017
1	Pain (Aches) 04/2015
1	Procedural Pain 04/2015

3	Iloprost (Ventavis)FDA Link 02/2024 - 09/2017
2	apremilastIBA 02/2023 - 10/2022
2	Biosimilar PharmaceuticalsIBA 02/2022 - 01/2022
2	Antirheumatic Agents (DMARD)IBA 01/2022 - 01/2021
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2021
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 02/2024
1	VaccinesIBA 12/2023
1	COVID-19 VaccinesIBA 12/2023
1	Janus Kinase InhibitorsIBA 08/2023
1	tofacitinibIBA 08/2023
1	5-(tetradecyloxy)-2-furancarboxylic acid (TOFA)IBA 08/2023
1	CytokinesIBA 06/2023
1	Cytokine Receptors (Cytokine Receptor)IBA 06/2023
1	nintedanibIBA 06/2023
1	RNA (Ribonucleic Acid)IBA 06/2023
1	CannabidiolIBA 01/2023
1	Carbon MonoxideIBA 01/2023
1	anti-scl-70 autoantibodiesIBA 10/2022
1	phytobacteriomycin (PBM)IBA 06/2022
1	ABP 501IBA 02/2022
1	Adalimumab (Humira)FDA Link 02/2022
1	Etanercept (Enbrel)FDA Link 01/2022
1	SteroidsIBA 01/2022
1	IgA receptor (protein B)IBA 01/2022
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2022
1	Antinuclear AntibodiesIBA 01/2022
1	AutoantibodiesIBA 01/2022
1	CalciumIBA 04/2020
1	FibrinIBA 04/2020
1	neem oilIBA 04/2020
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 08/2019
1	TroponinIBA 06/2019
1	Oxygen (Dioxygen)IBA 11/2017
1	Rituximab (Mabthera)FDA Link 11/2015
1	Analgesics (Analgesic Drugs)IBA 04/2015
1	AntibodiesIBA 05/2013

3	Therapeutics 12/2022 - 11/2015
2	Debridement 06/2022 - 04/2015
1	Low-Level Light Therapy (LLLT) 06/2022
1	Surgical Amputation (Amputations) 02/2018
1	Hand Hygiene 02/2012